HDA has published “A Year in Review,” which chronicles the Alliance’s 2019 activities. Highlighted accomplishments include:
- The Alliance’s continued commitment to communicating the value of distribution through the “Role of Distributors” report as well as the Health Delivered initiative.
- HDA’s advocacy efforts surrounding healthcare affordability and prescription drug importation as well as its support for supply chain resiliency efforts.
- The organization’s leadership on mitigating the opioid crisis through practical policy solutions and Allied Against Opioid Abuse; and,
- The continued growth of HDA’s professional development initiatives, such as Emerging Leaders.
“As the national organization representing a vital part of the pharmaceutical supply chain, continuity … plays an important role in what HDA does, as a strong voice for the industry since 1876,” the report notes. “While the next decade will certainly bring changes and challenges for the organization and our members, HDA will remain committed to serving the industry and its members, just as these entities sustain hundreds of thousands of pharmacies, hospitals and other providers every day.”
For more information, contact Farah Simonett.
ABOUT THE HEALTHCARE DISTRIBUTION ALLIANCE
The Healthcare Distribution Alliance (HDA) represents primary pharmaceutical distributors — the vital link between the nation’s pharmaceutical manufacturers and pharmacies, hospitals, long-term care facilities, clinics and others nationwide. Since 1876, HDA has helped members navigate regulations and innovations to get the right medicines to the right patients at the right time, safely and efficiently. The HDA Research Foundation, HDA’s non-profit charitable foundation, serves the healthcare industry by providing research and education focused on priority healthcare supply chain issues.